Causes and Risk Factors for Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) is a type of cancer that begins in white blood cells (lymphocytes) in the bone marrow and then spreads to the blood. Understanding the chronic lymphocytic leukemia causes and chronic lymphocytic leukemia risk factors is crucial for both prevention and early detection.

Key Takeaways
- Most CLL cases have no single identifiable cause; the disease develops when genetic changes build up in B lymphocytes over a person’s lifetime.
- Age is the strongest risk factor: CLL is rare before age 45, and the typical age at diagnosis is 71.
- Men are diagnosed with CLL somewhat more often than women, and White Americans are diagnosed more often than people of other racial backgrounds.
- A family history of CLL can raise risk, and monoclonal B-cell lymphocytosis (MBL), a precursor condition, is more frequent among relatives of people with CLL.
- No link to radiation exposure has been established, but Agent Orange exposure during the Vietnam War has been tied to a slightly higher risk.
What Causes Chronic Lymphocytic Leukemia?
The exact cause of CLL is not known. Rather than a single trigger, the disease is understood to result from genetic changes that build up within B lymphocytes, immune cells produced in the bone marrow, over a person’s lifetime. Most cases are not linked to a known inherited cause.
Genetic Mutations and Cell Changes
In CLL, abnormal B lymphocytes multiply and build up in the blood, bone marrow, and lymphoid tissue instead of being cleared through the body’s normal processes. As these cells build up, there is less room in the bone marrow for the body to make normal blood cells. To look for chromosome changes within the leukemia cells, doctors often use a laboratory technique called fluorescence in situ hybridization (FISH), which can detect deletions on chromosome 13q, 11q, or 17p, or an extra copy of chromosome 12 (trisomy 12). A deletion on chromosome 17p is associated with loss of the TP53 gene, which normally helps regulate cell growth. How these specific changes affect a person’s outlook and treatment path is covered in more detail on this site’s CLL stages and survival pages.
Immune System Dysregulation
Because CLL originates in B lymphocytes — the very cells that help the body fight infection — the disease disrupts normal immune function as it progresses. As leukemia cells build up in the bone marrow, the body has fewer working white blood cells to respond to infection, which is why increased susceptibility to infection is a common feature of CLL. Whether changes in immune regulation help trigger CLL, rather than simply resulting from it, is not yet well established.
Key Risk Factors for CLL Development
Several factors are associated with a higher likelihood of developing CLL. Having one or more of these factors does not mean a person will develop the disease, and most people diagnosed with CLL have no other clearly identifiable risk factor beyond their age.
Age and Gender Demographics
Age is the single most significant risk factor for CLL. The disease is rare in people younger than 45 and becomes more common with each decade of life; according to SEER data from the National Cancer Institute, the typical age at diagnosis is 71, and more than 9 in 10 new cases are diagnosed in people age 55 or older. Men develop CLL somewhat more often than women, a pattern seen across most age groups, though the reason for this difference is not fully understood. These are population-level patterns and do not predict any one person’s individual risk.
Family History and Ethnicity
Some people with CLL have close relatives who have also been diagnosed with the disease, indicating that family history plays a role in a subset of cases; this genetic link is explored further in the next section. In the United States, White people are diagnosed with CLL more often than people of other races, a pattern seen consistently in national data. As with age and sex, this reflects group-level patterns rather than a specific individual’s risk.
Genetic Predisposition to Chronic Leukemia
Although most CLL cases arise from mutations acquired during a person’s lifetime rather than inherited ones, a subset of individuals appears to have increased genetic susceptibility.
Inherited Gene Variants
Unlike some other cancers, no single gene test is currently used to identify people who have inherited a higher risk of CLL. Much of what is known about inherited susceptibility comes from the study of monoclonal B-cell lymphocytosis (MBL), a condition in which a small clone of CLL-like B cells circulates in the blood without meeting the criteria for CLL itself. According to the National Cancer Institute, MBL occurs in about 5% to 12% of the general adult population and becomes more common with age; the large majority of people with MBL never go on to develop CLL.
Familial CLL Patterns
CLL clustering within families provides evidence of an inherited component. According to NCI data, in families with two or more relatives diagnosed with CLL, MBL is found in 13% to 18% of unaffected relatives, a notably higher rate than in the general population. Even in these familial cases, MBL progresses to symptomatic CLL requiring treatment in fewer than 2% of people per year, and lower-level MBL rarely progresses at all. This pattern suggests that where inherited susceptibility exists, it more often involves a combination of subtle genetic factors rather than a single gene that guarantees the disease will develop.
Environmental Factors and CLL Risk
Compared with age, sex, and family history, environmental exposures appear to play a smaller and less consistent role in CLL risk.
Chemical Exposures
It remains unclear whether chemical exposures cause CLL. Benzene, found in gasoline, cigarette smoke, and some industrial settings, is a recognized cause of other types of leukemia, but its link to CLL specifically is less established. People exposed to Agent Orange while serving in the Vietnam War appear to face a slightly elevated chance of developing CLL, a link most relevant to veterans of that era.
Radiation and Other Toxins
Unlike some other blood cancers, CLL has no established link to radiation exposure. This sets it apart from leukemia types in which ionizing radiation is a recognized risk factor. No other environmental toxin has been consistently confirmed as a cause of CLL.
Frequently Asked Questions
Is CLL an inherited condition?
Most CLL is not inherited, and in most cases no specific cause can be identified. Some people with CLL do have close relatives with the disease, and monoclonal B-cell lymphocytosis, a CLL precursor, is more common among relatives of people with CLL than in the general population. A doctor can help evaluate family risk when multiple relatives are affected.
Can lifestyle choices prevent CLL?
There is no known way to prevent CLL through lifestyle changes. Its strongest risk factors — age, sex, and family history — cannot be modified, and no specific diet or behavior has been shown to lower risk. General healthy habits support overall well-being but have not been shown to directly change CLL risk.
How common is CLL?
In the United States, doctors diagnose CLL in adults more often than several other leukemia types, occurring mainly later in life. Detailed incidence figures and trends are covered on this site’s CLL statistics page.
Sources
- National Cancer Institute – Chronic Lymphocytic Leukemia Treatment (PDQ®)–Patient Version
- National Cancer Institute – Chronic Lymphocytic Leukemia Treatment (PDQ®)–Health Professional Version
- MedlinePlus – Chronic Lymphocytic Leukemia (CLL)
- National Cancer Institute – Cancer Stat Facts: Chronic Lymphocytic Leukemia